{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "16040974",
  "DateCompleted": {
    "Year": "2005",
    "Month": "08",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0019-9567",
      "JournalIssue": {
        "Volume": "73",
        "Issue": "8",
        "PubDate": {
          "Year": "2005",
          "Month": "Aug"
        }
      },
      "Title": "Infection and immunity",
      "ISOAbbreviation": "Infect Immun"
    },
    "ArticleTitle": "Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells.",
    "Pagination": {
      "StartPage": "4620",
      "EndPage": "4625",
      "MedlinePgn": "4620-5"
    },
    "Abstract": {
      "AbstractText": [
        "Several mechanisms for attachment and entry of Chlamydia have been proposed. We previously determined that the major outer membrane protein of Chlamydia trachomatis is glycosylated with a high-mannose oligosaccharide, and a similar structure inhibited the attachment and infectivity of C. trachomatis in epithelial cells. Because insulin-like growth factor 2 (IGF2) was shown to enhance the infectivity of Chlamydia pneumoniae but not C. trachomatis in endothelial cells, a hapten inhibition assay was used to analyze whether the mannose 6-phosphate (M6P)/IGF2 receptor that also binds M6P could be involved in infection of endothelial cells (HMEC-1) by Chlamydia. M6P and mannose 6-phosphate-poly[N-(2-hydroxyethyl)-acrylamide] (M6P-PAA) inhibited the infectivity of C. pneumoniae AR-39, but not C. trachomatis serovar UW5 or L2, while mannan inhibited the growth of C. trachomatis, but not C. pneumoniae. Using metabolically labeled organisms incubated with cells at 4 degrees C (organisms attach but do not enter) or at 37 degrees C (organisms attach and are internalized), M6P-PAA was shown to inhibit attachment and internalization of C. pneumoniae in endothelial cells but did not inhibit attachment or internalization of C. trachomatis serovar E or L2. These findings indicate that C. pneumoniae can utilize the M6P/IGF2 receptor and that the use of this receptor for attachment and entry differs between C. pneumoniae and C. trachomatis."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195, USA."
          }
        ],
        "LastName": "Puolakkainen",
        "ForeName": "Mirja",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kuo",
        "ForeName": "Cho-Chou",
        "Initials": "CC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Campbell",
        "ForeName": "Lee Ann",
        "Initials": "LA"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI043060",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI43060",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Infect Immun",
    "NlmUniqueID": "0246127",
    "ISSNLinking": "0019-9567"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Haptens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptor, IGF Type 2"
    },
    {
      "RegistryNumber": "EC 3.1.3.1",
      "NameOfSubstance": "Alkaline Phosphatase"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Alkaline Phosphatase"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "Chlamydia Infections"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "Chlamydia trachomatis"
    },
    {
      "QualifierName": [
        "drug therapy",
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "Chlamydophila Infections"
    },
    {
      "QualifierName": [
        "drug effects",
        "immunology",
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "Chlamydophila pneumoniae"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism",
        "microbiology"
      ],
      "DescriptorName": "Endothelial Cells"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Haptens"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Receptor, IGF Type 2"
    }
  ]
}